Low C reactive protein-alleles in hepatocyte nuclear factor 1A are associated with an increased risk of cardiovascular disease: a Meta-analysis.
肝細胞核因子1A中的低C反應蛋白等位基因與心血管疾病風險增加相關:一項Meta分析。
J Clin Endocrinol Metab 2024-08-30
Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes.
人類 GLP-1 受體罕見的異質性喪失功能變異與心臟代謝表現無關。
J Clin Endocrinol Metab 2023-11-03
Genetic variation in solute carrier family 5 member 2 mimicking sodium-glucose co-transporter 2-inhibition and risk of cardiovascular disease and all-cause mortality: reduced risk not explained by lower plasma glucose.
溶質載體家族5成員2基因變異模擬鈉葡萄糖共同運輸蛋白2抑制作用,與心血管疾病和全因死亡風險相關:降低風險並非由較低血漿葡萄糖解釋。
Cardiovasc Res 2023-11-24
A network meta-analysis of association between cardiometabolic risk factors and COVID-19 outcome severity.
心臟代謝風險因子與 COVID-19 結果嚴重程度之間的網絡 Meta 分析。
J Diabetes 2023-11-27
Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study.
Semaglutide作為HNF1B-MODY的潛在治療替代方案:一個案例研究。
Front Endocrinol (Lausanne) 2024-03-26
Novel Approach for Treating Diabetes in a Patient With the Heterozygous Pathogenic Variant R46Q in the Insulin Gene.
針對具有胰島素基因 R46Q 異質性致病變異的患者治療糖尿病的新方法。
JCEM Case Rep 2024-07-19
Renal and Extrarenal Phenotypes in Patients With <i>HNF1B</i> Variants and Chromosome 17q12 Microdeletions.
HNF1B 變異及 17q12 染色體微缺失患者的腎臟及腎外表現型。
Kidney Int Rep 2024-08-19
Variants in <i>PPARD</i>-<i>GLP1R</i> are related to diabetic kidney disease in Chinese Han patients with type 2 diabetes mellitus.
PPARD-GLP1R 變異與中國漢族 2 型糖尿病患者的糖尿病腎病相關。
Heliyon 2024-08-20
Hepatitis C virus infection is associated with proteinuria according to a systematic review with meta-analysis.
根據系統性回顧與統合分析,C型肝炎病毒感染與蛋白尿相關。
Nefrologia (Engl Ed) 2024-08-31